Table 1: Pretreatment characteristics.

PORT WPRT P

Age (years)71.973.10.57

PSAMean6.923.9
<10 ng/mL24200.015
10–20 ng/mL717
≥20 ng/mL021

Gleason scoreMean6.427.72
≤6186<0.01
=71321
≥8031

NCCN risk groupLow150
Intermediate1613
High045

Percent receiving hormonal ablation39%88%<0.01